Clinical Trial Update: Allogeneic Tumor Cell Vaccination in Patients With Chronic Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating an allogeneic tumor cell vaccine for chronic myeloid leukemia was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Allogeneic Tumor Cell Vaccination

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Chronic Myeloid Leukemia | Phase 1, Phase 2 | Status: WITHDRAWN